• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证 EuroSCORE II 在接受心脏瓣膜手术的中国患者中的应用。

Validation of EuroSCORE II in Chinese patients undergoing heart valve surgery.

机构信息

Department of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China.

出版信息

Heart Lung Circ. 2013 Aug;22(8):606-11. doi: 10.1016/j.hlc.2012.12.012. Epub 2013 Feb 1.

DOI:10.1016/j.hlc.2012.12.012
PMID:23375874
Abstract

BACKGROUND

To assess the performance of the The European System for Cardiac Operative. Risk Evaluation II (EuroSCORE II) in Chinese patients undergoing heart valve surgery at our centre.

METHODS

From January 2006 to December 2011, 3479 consecutive patients who underwent heart valve surgery at our centre were collected and scored according to the original EuroSCORE and EuroSCORE II models. All patients were divided into single valve surgery and multiple valve surgery subgroups. The entire cohort and each subgroup were analysed. Calibration of the original EuroSCORE and EuroSCORE II models was assessed by the Hosmer-Lemeshow (H-L) test. Discrimination was tested by calculating the area under the receiver operating characteristic (ROC) curve.

RESULTS

Observed mortality was 3.32% overall, compared to expected mortality 3.84% for the original additive EuroSCORE (H-L: P = 0.013), 3.33% for the original logistic EuroSCORE (H-L: P = 0.08), and 2.52% for the EuroSCORE II (H-L: P < 0.0001). The EuroSCORE II model showed good calibration in predicting in-hospital mortality for patients undergoing single valve surgery (H-L: P = 0.103) and poor calibration for patients undergoing multiple valve surgery (H-L: P < 0.0001). The discriminative power of the original EuroSCORE model (area under the ROC curve of 0.684 and 0.673 for the additive and logistic model, respectively) and EuroSCORE II model (area under the ROC curve of 0.685) for the entire cohort was poor. The discriminative power of the EuroSCORE II model was good for the single valve surgery group (area under the ROC curve of 0.792) and was poor for the multiple valve surgery group (area under the ROC curve of 0.605).

CONCLUSION

The EuroSCORE II model gives an accurate prediction for individual operative risk in patients undergoing single valve surgery but an imprecise prediction in patients undergoing multiple valve surgery at our centre. Therefore, the use of the EuroSCORE II model for risk evaluation may be suitable in patients undergoing single valve surgery, and the creation of a new model which accurately predicts outcomes in patients undergoing multiple valve surgery is possibly required at our centre in the future.

摘要

背景

评估欧洲心脏手术风险评估系统 II (EuroSCORE II)在我院行心脏瓣膜手术的中国患者中的表现。

方法

2006 年 1 月至 2011 年 12 月,我院连续收治 3479 例心脏瓣膜手术患者,按原始 EuroSCORE 和 EuroSCORE II 模型进行评分。所有患者均分为单瓣膜手术和多瓣膜手术亚组。对整个队列和每个亚组进行分析。采用 Hosmer-Lemeshow(H-L)检验评估原始 EuroSCORE 和 EuroSCORE II 模型的校准情况。通过计算受试者工作特征(ROC)曲线下面积评估区分度。

结果

全组观察死亡率为 3.32%,与原始加性 EuroSCORE 的预期死亡率 3.84%(H-L:P = 0.013)、原始逻辑 EuroSCORE(H-L:P = 0.08)和 EuroSCORE II(H-L:P < 0.0001)相比。EuroSCORE II 模型在预测单瓣膜手术患者院内死亡率方面具有良好的校准(H-L:P = 0.103),但在预测多瓣膜手术患者时校准效果较差(H-L:P < 0.0001)。原始 EuroSCORE 模型(加性和逻辑模型的 ROC 曲线下面积分别为 0.684 和 0.673)和 EuroSCORE II 模型(ROC 曲线下面积为 0.685)对整个队列的区分能力均较差。EuroSCORE II 模型在单瓣膜手术组具有良好的区分能力(ROC 曲线下面积为 0.792),而在多瓣膜手术组区分能力较差(ROC 曲线下面积为 0.605)。

结论

在我院行单瓣膜手术的患者中,EuroSCORE II 模型能准确预测个体手术风险,但在多瓣膜手术患者中预测结果不精确。因此,在我院,EuroSCORE II 模型可能适用于单瓣膜手术患者的风险评估,而需要建立一个新的模型来准确预测多瓣膜手术患者的结局。

相似文献

1
Validation of EuroSCORE II in Chinese patients undergoing heart valve surgery.验证 EuroSCORE II 在接受心脏瓣膜手术的中国患者中的应用。
Heart Lung Circ. 2013 Aug;22(8):606-11. doi: 10.1016/j.hlc.2012.12.012. Epub 2013 Feb 1.
2
Comparison of four risk scores for in-hospital mortality in patients undergoing heart valve surgery: A multicenter study in a Chinese population.心脏瓣膜手术患者院内死亡四种风险评分的比较:一项中国人群的多中心研究
Heart Lung. 2016 Sep-Oct;45(5):423-8. doi: 10.1016/j.hrtlng.2016.06.002. Epub 2016 Jul 21.
3
Validation of the European system for cardiac operative risk evaluation (EuroSCORE) in Chinese heart valve surgery patients.欧洲心脏手术风险评估系统(EuroSCORE)在中国心脏瓣膜手术患者中的验证。
J Heart Valve Dis. 2010 Jan;19(1):21-7.
4
Comparison of six risk scores for in-hospital mortality in Chinese patients undergoing heart valve surgery.中文版患者接受心脏瓣膜手术后院内死亡率的六种风险评分比较。
Heart Lung Circ. 2013 Aug;22(8):612-7. doi: 10.1016/j.hlc.2013.03.084. Epub 2013 Apr 22.
5
Performance of European system for cardiac operative risk evaluation in Veterans General Hospital Kaohsiung cardiac surgery.高雄荣民总医院心脏手术之欧洲心脏手术风险评估系统表现。
J Chin Med Assoc. 2011 Mar;74(3):115-20. doi: 10.1016/j.jcma.2011.01.025. Epub 2011 Mar 1.
6
Is the European System for Cardiac Operative Risk Evaluation useful in Chinese patients undergoing heart valve surgery?欧洲心脏手术风险评估系统在中国行心脏瓣膜手术的患者中是否有用?
Chin Med J (Engl). 2012 Oct;125(20):3624-8.
7
Validation of EuroSCORE II on a single-centre 3800 patient cohort.在一个拥有3800名患者的单中心队列中对欧洲心脏手术风险评估系统II(EuroSCORE II)进行验证。
Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):293-300. doi: 10.1093/icvts/ivs480. Epub 2012 Nov 23.
8
Assessment of the EuroSCORE II in a New Zealand Tertiary Centre.新西兰一家三级医疗中心的 EuroSCORE II 评估。
Heart Lung Circ. 2019 Nov;28(11):1670-1676. doi: 10.1016/j.hlc.2018.09.004. Epub 2018 Sep 27.
9
Prospective validation of EuroSCORE II in patients undergoing cardiac surgery in Argentinean centres.欧洲心脏手术风险评估系统II(EuroSCORE II)在阿根廷各中心接受心脏手术患者中的前瞻性验证。
Interact Cardiovasc Thorac Surg. 2014 May;18(5):539-43. doi: 10.1093/icvts/ivt550. Epub 2014 Feb 2.
10
Reliability of new scores in predicting perioperative mortality after mitral valve surgery.新评分系统预测二尖瓣手术后围手术期死亡率的可靠性。
J Thorac Cardiovasc Surg. 2014 Mar;147(3):1008-12. doi: 10.1016/j.jtcvs.2013.06.042. Epub 2013 Aug 28.

引用本文的文献

1
Performance Drift in Machine Learning Models for Cardiac Surgery Risk Prediction: Retrospective Analysis.用于心脏手术风险预测的机器学习模型中的性能漂移:回顾性分析
JMIRx Med. 2024 Jun 12;5:e45973. doi: 10.2196/45973.
2
Minimum heart rate and mortality after cardiac surgery: retrospective analysis of the Multi-parameter Intelligent Monitoring in Intensive Care (MIMIC-III) database.心脏手术后的最低心率与死亡率:对多参数智能监护重症监护数据库(MIMIC-III)的回顾性分析。
Sci Rep. 2023 Feb 14;13(1):2597. doi: 10.1038/s41598-023-29703-9.
3
Validation in Indonesia of two published scores for mortality prediction after cardiac surgery.
印度尼西亚对两种已发表的心脏手术后死亡率预测评分进行验证。
Ann Card Anaesth. 2023 Jan-Mar;26(1):23-28. doi: 10.4103/aca.aca_297_20.
4
Comparison of the safety and efficacy between minimally invasive cardiac surgery and median sternotomy in a low-risk mixed Asian population in Singapore.新加坡低危混合亚裔人群中微创心脏手术与正中胸骨切开术的安全性和疗效比较。
Singapore Med J. 2022 Nov;63(11):641-648. doi: 10.11622/smedj.2021136. Epub 2021 Oct 4.
5
Transcatheter mitral valve repair in a high-surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device-First in man implantation in China.经导管二尖瓣修复术在高手术风险的严重退行性二尖瓣反流患者中的应用——新型 DragonFly™ 经导管修复装置在中国的首例人体植入。
Catheter Cardiovasc Interv. 2022 Feb;99(2):518-521. doi: 10.1002/ccd.29687. Epub 2021 May 4.
6
Updating EuroSCORE by including emotional, behavioural, social and functional factors to the risk assessment of patients undergoing cardiac surgery: a study protocol.将情感、行为、社会和功能因素纳入心脏手术患者风险评估的 EuroSCORE 更新:研究方案。
BMJ Open. 2019 Jul 3;9(7):e026745. doi: 10.1136/bmjopen-2018-026745.
7
Can Elderly Patients with Severe Mitral Regurgitation Benefit from Trans-catheter Mitral Valve Repair?重度二尖瓣反流老年患者能否从经导管二尖瓣修复术中获益?
Korean Circ J. 2019 Jun;49(6):532-541. doi: 10.4070/kcj.2018.0417. Epub 2019 Feb 20.
8
Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study.希腊心脏手术人群中欧洲心脏手术风险评估系统(EuroSCORE II)的验证:一项前瞻性研究。
Open Cardiovasc Med J. 2017 Sep 30;11:94-101. doi: 10.2174/1874192401711010094. eCollection 2017.
9
Modifying risks to improve outcome in cardiac surgery: An anesthesiologist's perspective.改善心脏手术结局的风险调整:麻醉医生的观点
Ann Card Anaesth. 2017 Apr-Jun;20(2):226-233. doi: 10.4103/aca.ACA_20_17.
10
Mortality prediction in Indian cardiac surgery patients: Validation of European System for Cardiac Operative Risk Evaluation II.印度心脏手术患者的死亡率预测:欧洲心脏手术风险评估系统II的验证
Indian J Anaesth. 2017 Feb;61(2):157-162. doi: 10.4103/ija.IJA_522_16.